By Toni Clarke WASHINGTON, Oct 24 (Reuters) - The U.S. Food and Drug Administration on Thursday recommended tighter restrictions on p...
Read Whole Story
Plans for the manufacture and sale of hydrocodone pills five to 10 times more potent than is now available is a warning sign of an escalation of what we might call the "prescription opiate arms race" among pharmaceutical companies.
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.